There is a body of evidence that mind–body interventions (MBIs) can improve mental and physical health. Much of the literature has focused on stress reduction as the major mechanism related to beneficial outcome, such as use of virtual reality in reducing a patient’s anxiety over first clinical visit. In addition, the current research has shown strong associations of biological and physical changes occurring during MBI’s. Yet, outside our understanding that stress has major implications on the state of a patient’s immune system, little research has been performed on the physiologic, cellular, and molecular changes occurring with such interventions. Stress can be regarded as a bodily response to events that are perceived as a threat or a challenge. This response may precipitate a health risk when stress is severe, or it occurs over a long period of time without adequate coping mechanisms. It has been found that exposure to severe stressors can have a profound influence on the body and can lead to detrimental changes in its biology and determining such molecular signatures could present as surrogate biomarkers for choice of MBI. In addition, other confounding factors, such as diet, exercise, and environmental factors may play a role in gene expression and epigenetic changes occurring in patients and the benefits of different MBI’s which could alleviate stressors and promote their rehabilitation. The advent of genomics technologies has given rise to a new era of personalized medicine, in which the therapeutic strategy can be tailored for a patient’s total needs, including all matters relating to well-being. In this regard, although much advance has been made on personalizing pharmacologic therapy, little research has been performed on whether there is a genetic component to non-pharmacologic aspects of rehabilitation and treatment, such as determining which patients respond more favorably to use of virtual reality. The goal for this symposium is to foster a discussion, in an interdisciplinary setting, on best practice strategies for effective rehabilitation for patients suffering from acute and chronic debilitative illness. The symposium brings together experts in rehabilitative medicine, physio-therapy, psychology and psychiatry, integrative technologies like virtual reality and artificial intelligence in pathological diagnosis, biochemistry, and geneticists.


Prof.ssa Maria Luisa Balestrieri

Prof. Antonio Giordano

Prof.ssa Francesca Gimigliano

Prof. Andrea Fiorillo

Prof. Raffaele Landolfi

Dr. Luigi Gallo

Prof.ssa Gaia Sampogna

Dr.ssa Nunzia D’Onofrio

Dr. Marco Paoletta

Dr. Andrea Ronchi

Prof. Andrea Chirico

Prof. Steven Hwang

Dr. Paolo Chiariello

Prof. Italo Francesco Angelillo

Prof. Michelino De Laurentiis

Dr. Giuseppe De Pietro

Prof. Renato Franco

Prof. Marcellino Monda

Dr.ssa Monica Pinto